Sign in Subscribe
Fees

Cytokinetics Class Action Lawsuit: Deadline for Lead Plaintiff Approaching

Strategic Insights

— 1 min read

A class action lawsuit has been filed against Cytokinetics, Inc. (NASDAQ: CYTK) on behalf of investors who purchased the company's common stock between December 27, 2023, and May 6, 2025. The lawsuit alleges that defendants made false and/or misleading statements regarding the timeline for the New Drug Application (NDA) submission and approval process for aficamten. The lead plaintiff deadline is November 17, 2025, and investors who wish to serve as lead plaintiff must move the Court by this date.

Key Takeaways:

  • The lawsuit alleges that Cytokinetics' executives made false and/or misleading statements about the company's expected approval from the FDA for its NDA for aficamten in the second half of 2025.
  • The defendants failed to disclose material risks related to Cytokinetics' failure to submit a Risk Evaluation and Mitigation Strategy (REMS) that could delay the regulatory process.
  • Investors who purchased Cytokinetics common stock during the Class Period (December 27, 2023 to May 6, 2025) may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
  • The Rosen Law Firm represents investors throughout the globe and has a track record of success in securities class actions and shareholder derivative litigation.
  • The firm achieved the largest-ever securities class action settlement against a Chinese Company at the time and has recovered hundreds of millions of dollars for investors.

Statistics:

  • Cytokinetics' common stock was purchased by investors between December 27, 2023, and May 6, 2025.
  • The Class Period is from December 27, 2023, to May 6, 2025.
  • The lead plaintiff deadline is November 17, 2025.
  • Over $438 million was recovered for investors in 2019 alone by the Rosen Law Firm.
  • Laurence Rosen, the firm's founding partner, was named by Law360 as a Titan of Plaintiffs' Bar in 2020.

Sources:

  • Newsfile Corp. - October 26, 2025
  • The Rosen Law Firm's website: https://rosenlegal.com/
  • Law360: Laurence Rosen named Titan of Plaintiffs' Bar in 2020.
  • ISS Securities Class Action Services: 2017 rankings.
  • Super Lawyers and Lawdragon: recognition of Rosen Law Firm's attorneys.

Read more